“…Although manganites have not yet been used in hyperthermia or any other biomedical treatments, many different materials, exhibiting relatively low T c , including Cu–Ni, 12,13 Pd–Ni, 14,15 Fe–Pt, 16 Pd–Co, 17,18 and Ni–Si 19 alloys, Co 1− x Zn x Fe 2 O 4 , 20 Y 3 Fe 5− x Al x O 12 , 20 Fe 66 P 13 C 7 Cr 14 amorphous flakes 21 , and others have been used, albeit in the majority of cases as stationary, interstitial implants. - It has been shown that successful in vivo attachment of magnetic particles is—in certain cases of larger entities, such as cells—not limited to nano‐sized particles, but could be even more significant when micrometer or submicrometer sized magnetic particles are used, 1 depending largely on the tissue or the organ concerned 22 . Whereas it is said that extracellular maneuvers are limited to particles less than 50 nm in size 23 (with natural, ferritin particles being 9 nm in diameter and diffusing rapidly through intercellular space 3 ), micrometer sized particles (wherein, even though the smallest capillaries in the body are 5–6 μm in diameter, 22 particles as large as 200 μm on average were successfully applied 21,24 ) are better suited to withstand the flow dynamics in the circulatory system 1 . Particles of moderate size range (∼200 nm), 25 such as the ones prepared within this work, might therefore be optimally suited for the promotion of in vivo drug‐targeting effects.
…”